Global Sickle-cell Anemia Therapeutics Market Size, Status and Forecast 2020-2026

Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
In the last several years, global market of Sickle Cell Anemia Therapeutics developed rapidly, with an average growth rate of 13.32% during 2013 to 2017. In 2017, global revenue of Sickle Cell Anemia Therapeutics is nearly 1900 M USD.
Market Analysis and Insights: Global Sickle-cell Anemia Therapeutics Market
In 2019, the global Sickle-cell Anemia Therapeutics market size was US$ 1633.2 million and it is expected to reach US$ 4406.3 million by the end of 2026, with a CAGR of 15.0% during 2021-2026.
Global Sickle-cell Anemia Therapeutics Scope and Market Size
Sickle-cell Anemia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sickle-cell Anemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Segment by Type, the Sickle-cell Anemia Therapeutics market is segmented into Blood Transfusion, Pharmacotherapy, Bone Marrow Transplant, etc.
Segment by Application, the Sickle-cell Anemia Therapeutics market is segmented into Child, Adult, etc.
Regional and Country-level Analysis
The Sickle-cell Anemia Therapeutics market is analysed and market size information is provided by regions (countries).
The key regions covered in the Sickle-cell Anemia Therapeutics market report are North America, Europe, China, Japan, Southeast Asia, India and Central & South America, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of revenue for the period 2015-2026.

Competitive Landscape

and Sickle-cell Anemia Therapeutics Market Share Analysis
Sickle-cell Anemia Therapeutics market competitive landscape provides details and data information by vendors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by player for the period 2015-2020. Details included are company description, major business, company total revenue and the revenue generated in Sickle-cell Anemia Therapeutics business, the date to enter into the Sickle-cell Anemia Therapeutics market, Sickle-cell Anemia Therapeutics product introduction, recent developments, etc.
The major vendors include Addmedica, Gamida Cell, GlycoMimetics, Pfizer, Novartis, Global Blood Therapeutics, Micelle BioPharma, Bluebird Bio, Prolong Pharmaceuticals, Modus Therapeutics, Sangamo Biosciences, Bioverativ, Imara, Ironwood Pharmaceuticals, etc.

This report focuses on the global Sickle-cell Anemia Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sickle-cell Anemia Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals

Market segment by Type, the product can be split into

Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant

Market segment by Application, split into

Child
Adult

Market segment by Regions/Countries, this report covers

North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:

To analyze global Sickle-cell Anemia Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Sickle-cell Anemia Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Sickle-cell Anemia Therapeutics are as follows:
History Year: 2015-2019

Base Year:

2019

Estimated Year:

2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.